| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $170.2M | -25.1% |
| R&D Expense | $243.8M | -42.5% |
| SG&A Expense | $183.3M | -25.5% |
| Operating Income | -$315.3M | +43.7% |
| Pre-tax Income | -$313.6M | +42.7% |
| Income Tax | -$837K | -74.7% |
| Net Income | -$312.8M | +42.8% |
| EPS (Basic) | -$5.64 | +46.5% |
| EPS (Diluted) | -$5.64 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $167.2M | -70.2% |
| Short-term Investments | $255.4M | — |
| Accounts Receivable | $24.0M | +9.9% |
| Current Assets | $471.8M | -21.7% |
| Total Assets | $1.12B | -18.7% |
| Current Liabilities | $96.0M | -10.5% |
| Total Liabilities | $611.1M | -7.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$171.1M | +46.5% |
| Capital Expenditures | $7.7M | -87.7% |
| Investing Cash Flow | -$240.3M | -286.1% |
| Financing Cash Flow | $17.8M | +1122.1% |
| Free Cash Flow | -$178.7M | +53.2% |
| +46.5% |
| Stockholders' Equity |
| $508.6M |
| -29.0% |